Show All Category
Endotracheal Tube, Cuffed

Safety Blood Lancet – NME000501

Safety Blood Lancet

Description
Ref. No.: Description: Gauge/Depth:
NME000501 Yellow (Junior) 26G/1.8mm, 2.4mm
NME000503 Orange (Comfort) 21G/2.2mm
NME000504 Green (Comfort) 21G/1.8mm
Safety Blood Lancet – NME000501, from Nexgen Medical Products Online store the USA. When it comes to capillary blood glucose monitoring, the necessity of a lancet is crucial to draw the sample. Safety lancets are retractable needles that prevent accidental pricks and reduce the risk of infection. With an in-built single-use system, these lancets are excellent travel partners. This high-speed device ensures minimal prick sensation, yet draws an adequate amount of blood for testing. Safety Blood Lancet With an advantage to prevent sharp injuries, safety lancets offer great advantages to all professionals in a clinical environment. With the ability to puncture and penetrate to a predetermined depth during sample collection, safety lancets in a way become specific and personalized to every patient type. The Needlestick Safety and Prevention Act (NSPA) (HR.5178) was signed into law on November 6, 2000. It required employers to provide safety-engineered medical devices to employees that are at risk for exposure to bloodborne pathogens. The NSPA requires employers to:
  • Identify, evaluate and implement safer medical devices.
  • Maintain a sharps injury log.
  • Involve healthcare workers in deciding which devices are used.
  • Implement engineering controls for sharps disposal containers, self-sheathing needles, Safety Blood Lancet  safer medical devices (e.g., sharps with engineered injury protections and needleless systems). It also requires those engineering controls to be used to eliminate or lessen employee exposure to bloodborne pathogens.
  • Train employees in the proper usage of the engineering and work practice control to help keep them safe.
The NSPA quickly spurred the development of medical devices with sharps safety-engineered features, which improved healthcare workplace safety conditions. For example, The New England Journal of Medicine reported “a drop of about 38 percent in 2001 when the NSPA took effect” and that “subsequent injury rates, through 2005, remained well below pre-NSPA rates.” The Centers for Disease Control and Prevention (CDC) further reported a 31.6-percent reduction in sharps-related injuries in non-surgical hospital settings during 2001–06 following the NSPA’s enactment.